Total Payments
$3,943
2024 Payments
$240.77
Companies
38
Transactions
107
Medicare Patients
1,096
Medicare Billing
$221,623
Payment Breakdown by Category
Travel$1,991 (50.5%)
Food & Beverage$1,873 (47.5%)
Education$78.99 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,991 | 9 | 50.5% |
| Food and Beverage | $1,873 | 97 | 47.5% |
| Education | $78.99 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Veran Medical Technologies, Inc. | $1,351 | 4 | $0 (2019) |
| Olympus Corporation of the Americas | $665.55 | 7 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $199.24 | 13 | $0 (2023) |
| GlaxoSmithKline, LLC. | $198.66 | 12 | $0 (2020) |
| Becton, Dickinson and Company | $187.96 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $126.88 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $113.69 | 7 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $105.24 | 2 | $0 (2024) |
| United Therapeutics Corporation | $86.15 | 2 | $0 (2017) |
| Mallinckrodt LLC | $80.73 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240.77 | 9 | Actelion Pharmaceuticals US, Inc. ($78.99) |
| 2023 | $225.15 | 11 | AstraZeneca Pharmaceuticals LP ($51.33) |
| 2022 | $35.11 | 2 | Merck Sharp & Dohme LLC ($21.14) |
| 2021 | $67.77 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($30.81) |
| 2020 | $29.50 | 2 | GlaxoSmithKline, LLC. ($14.94) |
| 2019 | $521.66 | 21 | Veran Medical Technologies, Inc. ($158.38) |
| 2018 | $2,406 | 34 | Veran Medical Technologies, Inc. ($1,192) |
| 2017 | $416.30 | 24 | Boehringer Ingelheim Pharmaceuticals, Inc. ($116.98) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $78.99 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/01/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Airway Clearance Device | ||||||
| 09/13/2024 | ABBVIE INC. | ALLODERM (Device) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: PLASTIC SURGERY | ||||||
| 07/30/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $14.30 | General |
| Category: Medical Device | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Respiratory | ||||||
| 06/20/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Pulmonology | ||||||
| 05/21/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Pulmonology | ||||||
| 05/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Respiratory | ||||||
| 12/13/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Respiratory | ||||||
| 12/06/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Respiratory | ||||||
| 11/02/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.23 | General |
| Category: Cardiovascular | ||||||
| 09/06/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Immunology | ||||||
| 06/23/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Respiratory | ||||||
| 05/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Respiratory | ||||||
| 05/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| Category: Medical Device | ||||||
| 04/07/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/16/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: NEUROLOGY | ||||||
| 07/12/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, COMBIVENT RESPIMAT | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/07/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Respiratory | ||||||
| 07/21/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 178 | 290 | $190,995 | $38,332 |
| 2022 | 10 | 254 | 341 | $135,778 | $39,324 |
| 2021 | 7 | 275 | 421 | $163,810 | $64,263 |
| 2020 | 11 | 389 | 616 | $206,116 | $79,704 |
Total Patients
1,096
Total Services
1,668
Medicare Billing
$221,623
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 89 | 170 | $161,495 | $28,654 | 17.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 61 | $11,358 | $3,700 | 32.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 25 | $6,692 | $2,341 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 22 | $5,241 | $1,999 | 38.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $6,210 | $1,638 | 26.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 88 | 146 | $96,559 | $24,197 | 25.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 58 | 79 | $15,655 | $6,224 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 22 | $4,286 | $2,271 | 53.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $5,827 | $2,264 | 38.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,038 | $1,878 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 17 | $2,229 | $1,223 | 54.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,169 | $951.00 | 43.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 12 | 13 | $1,714 | $125.24 | 7.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 13 | 14 | $1,898 | $99.96 | 5.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 11 | 11 | $1,403 | $90.56 | 6.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 130 | 252 | $131,040 | $47,781 | 36.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 64 | 84 | $13,440 | $7,120 | 53.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 24 | 24 | $7,560 | $4,027 | 53.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 19 | $3,230 | $2,007 | 62.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $3,510 | $1,574 | 44.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,080 | $1,362 | 44.2% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2021 | 12 | 13 | $1,950 | $392.26 | 20.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 134 | 327 | $170,040 | $62,032 | 36.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 74 | 104 | $16,640 | $8,826 | 53.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 26 | 26 | $7,280 | $3,186 | 43.8% |
About Dr. Idrees Mogri, MD
Dr. Idrees Mogri, MD is a Critical Care Medicine healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1184836355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Idrees Mogri, MD has received a total of $3,943 in payments from pharmaceutical and medical device companies, with $240.77 received in 2024. These payments were reported across 107 transactions from 38 companies. The most common payment nature is "Travel and Lodging" ($1,991).
As a Medicare-enrolled provider, Mogri has provided services to 1,096 Medicare beneficiaries, totaling 1,668 services with total Medicare billing of $221,623. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Dallas, TX
- Active Since 05/03/2007
- Last Updated 06/16/2022
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1184836355
Products in Payments
- Spin (Device) $1,351
- Olympus EBUS Bronchoscopes (Device) $665.55
- CFN PleurX (Device) $187.96
- TRELEGY ELLIPTA (Drug) $141.53
- ORENITRAM (Drug) $86.15
- OFEV (Drug) $81.52
- OFIRMEV (Drug) $80.73
- ZERBAXA (Drug) $79.71
- OPSUMIT (Drug) $78.99
- DUPIXENT (Biological) $71.11
- FASENRA (Biological) $60.49
- NUCALA (Biological) $57.13
- ELIQUIS (Drug) $50.66
- XARELTO (Drug) $48.84
- Prolastin-C Liquid (Biological) $48.09
- STIOLTO RESPIMAT (Drug) $41.67
- Precision Flow (Device) $41.22
- SPIRIVA (Drug) $36.88
- CHANTIX (Drug) $36.28
- LONHALA MAGNAIR (Drug) $35.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Dallas
Dr. Yolanda Mageto, Md, MD
Critical Care Medicine — Payments: $248,495
Critical Care Medicine $248,495
Sonja Bartolome, M.d, M.D
Critical Care Medicine — Payments: $194,111
Critical Care Medicine $194,111
Corey Kershaw, Md, MD
Critical Care Medicine — Payments: $116,660
Critical Care Medicine $116,660
Dr. Jagadeshwar Reddy, M.d, M.D
Critical Care Medicine — Payments: $10,977
Critical Care Medicine $10,977
Mr. Humayun Anjum, M.d, M.D
Critical Care Medicine — Payments: $10,184
Critical Care Medicine $10,184
Todd Grazia, Md, MD
Critical Care Medicine — Payments: $8,074
Critical Care Medicine $8,074